Immuneering

Forecast & Rating7 analysts currently cover Immuneering, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $17.17, about 321.8% upside from the current price of $4.07. Price targets range from $12.00 to $30.00 — a wide spread, showing clear disagreement over just how much Immuneering can rise. For you, this means most professionals who study Immuneering closely still see room for the stock to rise. Data as of Sep 28, 2026; for reference only and not investment advice.